Samsung Biologics 2024 Net Profit Surges 26 Percent on Record Sales
Seoul: Samsung Biologics Co., a biotech arm of the Republic of Korea’s Samsung Group, has reported a significant 26.3 percent increase in its 2024 net profit, amounting to 1.08 trillion won (US$753 million). This growth is attributed to record sales